http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
Clinical applications of continuous performance tests
measuring attention and impulsive responding in children and adults
Ch. 1. Neurobiology of attention and executive control -- Attention and executive control -- Neuropsychological models of attention -- Neurochemical basis of attention -- Asymmetry of attention -- Neuropsychological models of executive control -- Developmental issues -- Summary -- Ch. 2. Continuous performance test paradigms and what they do -- The original CPT paradigm -- Modifications of the original paradigm -- Effects of differences in CPT parameters -- Other factors known to influence CPT performance -- Scores reported for the CPT -- Summary -- Ch. 3. Major CPTs in clinical use: configuration, use, and technical adequacy -- Task demands and descriptive information -- The Conners Continuous Performance Test -- Gordon diagnostic system -- Integrated (or intermediate) visual and auditory -- Continuous performance test -- Test of variables of attention -- Adequacy of normative data -- Conners CPT -- GDS -- IVA -- TOVA and TOVA-A -- Summary -- CPT score formats and tables -- Conners CPT -- GDS -- IVA -- TOVA and TOVA-A -- Interpretive guidance -- Conners CPT -- GDS -- IVA -- TOVA and TOVA-A -- Reliability and validity studies -- Conners CPT -- GDS -- IVA -- TOVA and TOVA-A -- Discussion and conclusion -- Ch. 4. The relationship of CPTs to other cognitive and behavioral measures -- Construct validity -- Relations with other measures -- Cognitive measures -- Achievement -- Memory and learning -- Behavior rating scales -- Personality and symptom presentation in adults -- Other measures -- Summary -- Ch. 5. Brain-behavior correlates of CPT scores -- Support for CPT performance as reflecting CNS dysfunction -- Effects of diffuse damage -- Anterior-posterior gradient -- Differential response to target stimuli -- Asymmetry -- Neural substrates of CPT performance and psychopathology -- Effects of task variations on neurophysiological correlates -- Association with demographic variables -- Summary -- Ch. 6. Diagnostic efficacy of CPTs for disorders -- Usually first evident in childhood or adolescence -- Sensitivity and specificity -- Differential group performance -- CPTs and ADHD -- ADHD-LD comparisons -- ADHD-conduct disorder comparisons -- ADHD and other group comparisons -- CPTs and LD -- Schizophrenia, high risk for schizophrenia, and CPTs -- Schizophrenia -- Parental schizophrenia -- CPTs and CD -- CPTs and Tourettes syndrome -- CPTs and other groups -- Summary and conclusions
Ch. 7. Diagnostic efficacy of CPTs for disorders -- In adulthood -- CPTs and adult ADHD -- CPTs and adult schizophrenia -- Age and medication effects -- Familial schizophrenia -- Active schizophrenia and cases in remission comparison with other groups -- Summary -- CPTs and bipolar disorder -- CPTs and the dementias -- CPTs and TBI in adults -- CPTs and environmental neurotoxic exposure -- CPTs and renal disease -- CPTs and other groups -- Summary -- Ch. 8. Monitoring medication effects with continuous performance tests -- Psychostimulants -- Antidepressants -- Tricyclics -- MAOIs -- Atypical antidepressants -- SSRIs -- Neuroleptic medications -- Antianxiety (anxiolytic) and antihypertensive medications -- Anxiolytics -- Antihypertensives -- Anticonvulsants/antiepileptics -- Other medications -- Lithium -- Analgesics -- Nootropics -- Antihistamines and asthma medications -- Studies with leisure drugs, caffeine, nicotine, or high sugars -- Caffeine and nicotine -- Sugars and carbohydrates -- Summary -- Ch. 9. CPTs in monitoring effectiveness of other treatment approaches -- Status of empirical support for treatment programs -- CPTs as a pre-/postindex of effectiveness -- Other outcome measures -- Summary -- Ch. 10. Where do we go from here? -- Will the real CPT please stand up? -- Standardization of administration -- Technical adequacy -- Sensitivity and specificity -- Why use the CPT? -- Where to from here?
Cynthia A. Riccio, Cecil R. Reynolds, Patricia A. Lowe.
Includes bibliographical references (pages 315-373) and indexes.
Attention Deficit Disorder with Hyperactivity
Disruptive, Impulse Control, and Conduct Disorders